Here are Thursday's biggest analyst calls: Nvidia, SpaceX, Tesla, Ferrari, Meta, Apple, AMD, Yum & more
Analysts made several calls on Thursday, including Truist initiating Nebius with a Buy rating and $355 price target, Deutsche Bank initiating Clover Health with a Buy rating and $6 target, and Wells Fargo upgrading Synopsys and Yum Brands. Morgan Stanley initiated Revolution Medicine and upgraded TC Energy and DT Midstream. JPMorgan upgraded Meta to Overweight with an $820 target and reiterated Tesla as Neutral.
How this was made
The 30-second read
Why it matters
The collective analyst sentiment signals a broadly bullish stance on AI‑related and growth stocks, though some downgrades temper optimism.
Market read
The roundup adds fresh analyst viewpoints that may influence short‑term trading decisions across a wide set of equities.
What to watch
Potential macro‑risk from upcoming Fed decisions could dampen enthusiasm.
Background
Analyst houses released a batch of new initiations, upgrades, and price target changes across technology, healthcare, and industrial sectors.
Ticker impact
Deutsche Bank initiates coverage of Clover Health with a Buy rating and $6 price target.
Potential modest upside as investors price in new buy rating.
Buy rating and price target provide fresh catalyst for a small-cap health insurer.
Wells Fargo upgrades Synopsys to overweight from equal weight, citing AI demand momentum.
Likely short‑term rally on overweight call.
Weight change signals confidence in near‑term earnings growth.
Wells Fargo upgrades Yum Brands to overweight, calling it a high‑quality asset poised to re‑rate.
Potential modest upside as investors reassess valuation.
Weight change and bullish thesis provide fresh impetus.
TD Cowen initiates RELX as buy, calling it an AI beneficiary.
Likely modest upside.
Analyst initiation provides fresh catalyst.
Goldman Sachs initiates Abivax as buy with a 12‑month price target of $155.
Potential short‑term rally.
New coverage and price target add fresh market information.
Raymond James upgrades Casey's General Stores to outperform, setting a $750 target.
Possible modest upside.
Weight change and target price provide new catalyst.
Oppenheimer initiates Aehr Test Systems as outperform with a $120 price target.
Potential short‑term upside.
New coverage and target price constitute fresh catalyst.
JPMorgan initiates SK Hynix ADR as overweight with a $245 price target.
Likely modest rally.
Weight change and target price provide new market signal.
Market effects
Broad AI enthusiasm lifts multiple semiconductor and tech stocks.
US market likely sees modest gains in AI‑related equities.
Reinforces global AI hype, supporting related sectors worldwide.
Counterpoint
Some upgrades may be premature given valuation concerns; investors could wait for earnings.
Key entities
- AnalystWells Fargo
Provided upgrades to Synopsys and Yum Brands.
- AnalystJPMorgan
Upgraded Meta and issued neutral view on Tesla.
